Editorial
doi: 10.1016/j.healun.2009.11.605.
The globalization of clinical trials in pulmonary arterial hypertension
- PMID: 20113908
- DOI: 10.1016/j.healun.2009.11.605
Item in Clipboard
Editorial
The globalization of clinical trials in pulmonary arterial hypertension
J Heart Lung Transplant.
2010 Feb.
No abstract available
Comment in
-
Ethical issues associated with globalization of placebo-controlled in pulmonary arterial hypertension.J Heart Lung Transplant. 2010 Jul;29(7):825-6. doi: 10.1016/j.healun.2010.03.010. Epub 2010 Apr 24. J Heart Lung Transplant. 2010. PMID: 20456982 No abstract available.
Comment on
-
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.J Heart Lung Transplant. 2010 Feb;29(2):137-49. doi: 10.1016/j.healun.2009.09.005. J Heart Lung Transplant. 2010. PMID: 20022264 Clinical Trial.
-
Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension.J Heart Lung Transplant. 2010 Feb;29(2):150-6. doi: 10.1016/j.healun.2009.09.020. J Heart Lung Transplant. 2010. PMID: 20113907 Clinical Trial.
Similar articles
-
Long-term treprostinil in pulmonary arterial hypertension: Is the glass half full or half empty?Eur Respir J. 2006 Dec;28(6):1073-5. doi: 10.1183/09031936.00120506. Eur Respir J. 2006. PMID: 17138674 No abstract available.
-
Therapy for primary pulmonary hypertension.Can Respir J. 2003 Apr;10(3):169-70. doi: 10.1155/2003/254826. Can Respir J. 2003. PMID: 12712230 Review. No abstract available.
-
Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.Am J Cardiol. 2004 Apr 1;93(7):943-6. doi: 10.1016/j.amjcard.2003.12.031. Am J Cardiol. 2004. PMID: 15050507 Free PMC article. Clinical Trial.
-
Prostacyclin withdrawal in pulmonary hypertension #264.J Palliat Med. 2013 Feb;16(2):204-5. doi: 10.1089/jpm.2013.9529. Epub 2013 Jan 22. J Palliat Med. 2013. PMID: 23336356 Review. No abstract available.
-
Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension.Am J Ther. 2017 Sep/Oct;24(5):e620-e621. doi: 10.1097/MJT.0000000000000496. Am J Ther. 2017. PMID: 27574945 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
